Author

F. Betoudji

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

E. Nuermberger· 2 shared J. Lee· 2 shared S.-Y. Li· 2 shared A. Owen· 1 shared A. Upton· 1 shared H. Pertinez· 1 shared K. Mdluli· 1 shared N. C. Ammerman· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Nuermberger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy

Y. S. Chang, S.-Y. Li, H. Pertinez, F. Betoudji, J. Lee, S. Rannard, A. Owen, E. Nuermberger, N. C. Ammerman

bioRxiv · Apr 12, 2023Microbiology

Next-generation diarylquinolines improve sterilizing activity of regimens with pretomanid and the novel oxazolidinone TBI-223 in a mouse tuberculosis model

S.-Y. Li, P. J. Converse, F. Betoudji, J. Lee, K. Mdluli, A. Upton, N. Fotouhi, E. Nuermberger

This study evaluates new tuberculosis treatments in mice, finding that replacing bedaquiline with TBAJ-587 reduces relapse, while replacing linezolid with TBI-223 has no significant effect.

bioRxiv · Jan 10, 2023 · PreprintMicrobiology